Aapm 108

The 0.

Mark T. Madsen, Jon A. Anderson, James R. Halama, Jeff Kleck, Douglas J. Simpkin, John R.

Aapm 108

The 0. As a result, barrier shielding may be required in floors and ceilings as well as adjacent walls. Since the patient becomes the radioactive source after the radiopharmaceutical has been administered, one has to consider the entire time that the subject remains in the clinic. Information about the physical properties of the most commonly used clinical PET radionuclides is summarized, although the report primarily refers to fluorine Typical PET imaging protocols are reviewed and exposure rates from patients are estimated including self-attenuation by body tissues and physical decay of the radionuclide. Examples of barrier calculations are presented for controlled and noncontrolled areas. Shielding for adjacent rooms with scintillation cameras is also discussed. Tables and graphs of estimated transmission factors for lead, steel, and concrete at 0. Meeting the regulatory limits for uncontrolled areas can be an expensive proposition. Careful planning with the equipment vendor, facility architect, and a qualified more » medical physicist is necessary to produce a cost effective design while maintaining radiation safety standards. Similar records in OSTI. GOV collections:. Full Record Other Related Research.

Examples of barrier calculations are presented for controlled and noncontrolled areas.

AAPM is a scientific, educational, and professional nonprofit organization devoted to the discipline of physics in medicine. The information provided in this website is offered for the benefit of its members and the general public, however, AAPM does not independently verify or substantiate the information provided on other websites that may be linked to this site. Encrypted Login. Report No. The 0. As a result, barrier shielding may be required in floors and ceilings as well as adjacent walls.

AAPM is a scientific, educational, and professional nonprofit organization devoted to the discipline of physics in medicine. The information provided in this website is offered for the benefit of its members and the general public, however, AAPM does not independently verify or substantiate the information provided on other websites that may be linked to this site. Encrypted Login. Report No. The 0. As a result, barrier shielding may be required in floors and ceilings as well as adjacent walls. Since the patient becomes the radioactive source after the radiopharmaceutical has been administered, one has to consider the entire time that the subject remains in the clinic. Information about the physical properties of the most commonly used clinical PET radionuclides is summarized, although the report primarily refers to fluorine

Aapm 108

The 0. As a result, barrier shielding may be required in floors and ceilings as well as adjacent walls. Since the patient becomes the radioactive source after the radiopharmaceutical has been administered, one has to consider the entire time that the subject remains in the clinic. Information about the physical properties of the most commonly used clinical PET radionuclides is summarized, although the report primarily refers to fluorine Typical PET imaging protocols are reviewed and exposure rates from patients are estimated including self-attenuation by body tissues and physical decay of the radionuclide. Examples of barrier calculations are presented for controlled and noncontrolled areas. Shielding for adjacent rooms with scintillation cameras is also discussed.

Stickers pour twingo 2

Meeting the regulatory limits for uncontrolled areas can be an expensive proposition. View full fingerprint. Williams , Michael V. Medical physics. Conclusions: TG provides accurate dose estimates when there is no barrier between the patient and measurement location. Typical PET imaging protocols are reviewed and exposure rates from patients are estimated including self-attenuation by body tissues and physical decay of the radionuclide. The 0. Information about the physical properties of the most commonly used clinical PET radionuclides is summarized, although the report primarily refers to fluorine Since the patient becomes the radioactive source after the radiopharmaceutical has been administered, one has to consider the entire time that the subject remains in the clinic. Link to publication in Scopus.

.

Radiology - Physics Radiology. Together they form a unique fingerprint. Madsen , Jon A. View full fingerprint. The dosimeter measurements were compared to TG estimates by dividing the measured dose by the TG calculated dose. Information about the physical properties of the most commonly used clinical PET radionuclides is summarized, although the report primarily refers to fluorine Anderson , James R. Ex- amples of barrier calculations are presented for controlled and noncontrolled areas. Shielding for adjacent rooms with scintillation cameras is also discussed. Medical physics , 33 1 , AU - Votaw, John R. Since the patient becomes the radioactive source after the radiopharmaceutical has been administered, one has to consider the entire time that the subject remains in the clinic. Similar records in OSTI. The information provided in this website is offered for the benefit of its members and the general public, however, AAPM does not independently verify or substantiate the information provided on other websites that may be linked to this site.